{"entity":{"type":"insider","cik":"0001690460","url":"/insider/0001690460","json_url":"/insider/0001690460.json","name":"Dorsch Marion","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":15,"first":"2017-11-22","last":"2021-02-24","span_basis":"filed_date"},"name_variants":[{"name":"Dorsch Marion","source":"filing","n_filings":15,"first_seen":"2017-11-22","last_seen":"2021-02-24"}],"transactions":[{"id":4085235,"accession":"0001179110-21-002211","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-21-002211","line_url":"/filing/0001179110-21-002211#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001690460","owner_name":"Dorsch Marion","owner_display_name":"Dorsch Marion","owner_url":"/insider/0001690460","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7578.0,"shares_display":"7,578","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":757800.0,"total_display":"757,800.00","total_whole":"757,800","shares_owned_after":15250.0,"shares_owned_after_display":"15,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-22","filed_date":"2021-02-24","scope":"insider"},{"id":3013248,"accession":"0001179110-20-011988","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-011988","line_url":"/filing/0001179110-20-011988#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001690460","owner_name":"Dorsch Marion","owner_display_name":"Dorsch Marion","owner_url":"/insider/0001690460","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4600.0,"shares_display":"4,600","price_per_share":119.0,"price_display":"119.00","price_state":"stated","total_value":547400.0,"total_display":"547,400.00","total_whole":"547,400","shares_owned_after":15250.0,"shares_owned_after_display":"15,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-16","scope":"insider"},{"id":3013209,"accession":"0001179110-20-010351","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-010351","line_url":"/filing/0001179110-20-010351#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001690460","owner_name":"Dorsch Marion","owner_display_name":"Dorsch Marion","owner_url":"/insider/0001690460","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4600.0,"shares_display":"4,600","price_per_share":99.0,"price_display":"99.00","price_state":"stated","total_value":455400.0,"total_display":"455,400.00","total_whole":"455,400","shares_owned_after":15250.0,"shares_owned_after_display":"15,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-06","filed_date":"2020-10-08","scope":"insider"},{"id":3145474,"accession":"0001179110-20-009960","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-009960","line_url":"/filing/0001179110-20-009960#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001690460","owner_name":"Dorsch Marion","owner_display_name":"Dorsch Marion","owner_url":"/insider/0001690460","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4600.0,"shares_display":"4,600","price_per_share":89.0,"price_display":"89.00","price_state":"stated","total_value":409400.0,"total_display":"409,400.00","total_whole":"409,400","shares_owned_after":15250.0,"shares_owned_after_display":"15,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-23","filed_date":"2020-09-25","scope":"insider"},{"id":3293363,"accession":"0001179110-20-007715","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-007715","line_url":"/filing/0001179110-20-007715#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001690460","owner_name":"Dorsch Marion","owner_display_name":"Dorsch Marion","owner_url":"/insider/0001690460","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4600.0,"shares_display":"4,600","price_per_share":79.0,"price_display":"79.00","price_state":"stated","total_value":363400.0,"total_display":"363,400.00","total_whole":"363,400","shares_owned_after":15250.0,"shares_owned_after_display":"15,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-19","filed_date":"2020-06-23","scope":"insider"},{"id":2574958,"accession":"0001179110-20-004115","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-20-004115","line_url":"/filing/0001179110-20-004115","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001690460","owner_name":"Dorsch Marion","owner_display_name":"Dorsch Marion","owner_url":"/insider/0001690460","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1214.0,"shares_display":"1,214","price_per_share":52.49256177924217,"price_display":"52.49","price_state":"stated","total_value":63725.97,"total_display":"63,725.97","total_whole":"63,726","shares_owned_after":15250.0,"shares_owned_after_display":"15,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-23","filed_date":"2020-03-25","scope":"insider","n_lines":3},{"id":2574899,"accession":"0001179110-20-003475","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-003475","line_url":"/filing/0001179110-20-003475#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001690460","owner_name":"Dorsch Marion","owner_display_name":"Dorsch Marion","owner_url":"/insider/0001690460","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":536.0,"shares_display":"536","price_per_share":51.99,"price_display":"51.99","price_state":"stated","total_value":27866.64,"total_display":"27,866.64","total_whole":"27,867","shares_owned_after":16464.0,"shares_owned_after_display":"16,464","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-09","filed_date":"2020-03-11","scope":"insider"},{"id":8097585,"accession":"0001179110-19-013128","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-19-013128","line_url":"/filing/0001179110-19-013128#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001690460","owner_name":"Dorsch Marion","owner_display_name":"Dorsch Marion","owner_url":"/insider/0001690460","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4600.0,"shares_display":"4,600","price_per_share":79.0,"price_display":"79.00","price_state":"stated","total_value":363400.0,"total_display":"363,400.00","total_whole":"363,400","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-19","filed_date":"2019-12-23","scope":"insider"},{"id":8593711,"accession":"0001179110-19-007897","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-19-007897","line_url":"/filing/0001179110-19-007897#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001690460","owner_name":"Dorsch Marion","owner_display_name":"Dorsch Marion","owner_url":"/insider/0001690460","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4600.0,"shares_display":"4,600","price_per_share":99.0,"price_display":"99.00","price_state":"stated","total_value":455400.0,"total_display":"455,400.00","total_whole":"455,400","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-17","filed_date":"2019-06-19","scope":"insider"},{"id":8039040,"accession":"0001179110-19-003446","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-19-003446","line_url":"/filing/0001179110-19-003446","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001690460","owner_name":"Dorsch Marion","owner_display_name":"Dorsch Marion","owner_url":"/insider/0001690460","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":84.6621695652174,"price_display":"84.66","price_state":"stated","total_value":194722.99,"total_display":"194,722.99","total_whole":"194,723","shares_owned_after":107.0,"shares_owned_after_display":"107","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-04","filed_date":"2019-03-06","scope":"insider","n_lines":5},{"id":5958631,"accession":"0001179110-18-011550","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-18-011550","line_url":"/filing/0001179110-18-011550","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001690460","owner_name":"Dorsch Marion","owner_display_name":"Dorsch Marion","owner_url":"/insider/0001690460","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":70.47478260869565,"price_display":"70.47","price_state":"stated","total_value":162092.0,"total_display":"162,092.00","total_whole":"162,092","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-17","filed_date":"2018-09-19","scope":"insider","n_lines":3},{"id":6718944,"accession":"0001179110-18-004608","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-18-004608","line_url":"/filing/0001179110-18-004608#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001690460","owner_name":"Dorsch Marion","owner_display_name":"Dorsch Marion","owner_url":"/insider/0001690460","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":100.07,"price_display":"100.07","price_state":"stated","total_value":230161.0,"total_display":"230,161.00","total_whole":"230,161","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-15","filed_date":"2018-03-19","scope":"insider"},{"id":4731528,"accession":"0001179110-17-014599","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-17-014599","line_url":"/filing/0001179110-17-014599#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001690460","owner_name":"Dorsch Marion","owner_display_name":"Dorsch Marion","owner_url":"/insider/0001690460","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9166.0,"shares_display":"9,166","price_per_share":70.0,"price_display":"70.00","price_state":"stated","total_value":641620.0,"total_display":"641,620.00","total_whole":"641,620","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-22","filed_date":"2017-11-24","scope":"insider"},{"id":9242345,"accession":"0001179110-17-014597","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-17-014597","line_url":"/filing/0001179110-17-014597#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001690460","owner_name":"Dorsch Marion","owner_display_name":"Dorsch Marion","owner_url":"/insider/0001690460","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":64.44,"price_display":"64.44","price_state":"stated","total_value":32220.0,"total_display":"32,220.00","total_whole":"32,220","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-21","filed_date":"2017-11-24","scope":"insider"},{"id":4932152,"accession":"0001179110-17-014585","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-17-014585","line_url":"/filing/0001179110-17-014585","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001690460","owner_name":"Dorsch Marion","owner_display_name":"Dorsch Marion","owner_url":"/insider/0001690460","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17834.0,"shares_display":"17,834","price_per_share":65.48124873836493,"price_display":"65.48","price_state":"stated","total_value":1167792.59,"total_display":"1,167,792.59","total_whole":"1,167,793","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-21","filed_date":"2017-11-22","scope":"insider","n_lines":3},{"id":4932144,"accession":"0001179110-17-014585","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-17-014585","line_url":"/filing/0001179110-17-014585#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001690460","owner_name":"Dorsch Marion","owner_display_name":"Dorsch Marion","owner_url":"/insider/0001690460","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":64.44,"price_display":"64.44","price_state":"stated","total_value":32220.0,"total_display":"32,220.00","total_whole":"32,220","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-21","filed_date":"2017-11-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":26,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001597264","name":"Blueprint Medicines Corp","url":"/issuer/0001597264","role":"Officer (Chief Scientific Officer)","n_filings":15,"first_seen":"2017-11-22","last_seen":"2021-02-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001690460","retrieved_at":"2026-08-22T16:21:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}